Study of Inherited Gene Changes in Endometrial Cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how common certain inherited gene changes (like BRCA) are in people with endometrial cancer. It may help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with endometrial cancer.
- Your tumor has a BRCA gene mutation (a change in the BRCA gene in the cancer cells).
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This trial uses a simple blood test to look for two specific gene changes (ESR-1 and gBRCA) in people with hormone receptor-positive, HER2-negative breast cancer that has spread. It aims to detect these mutations earlier and help guide future treatment decisions.
This study uses advanced genetic testing (next-generation sequencing) to look at the molecular makeup of endometrial cancer or its rare subtype, carcinosarcoma. The goal is to better understand the cancer and possibly guide more personalized treatment.
This study will look at how certain genetic changes (in the TP53 gene and in chromosome stability) affect endometrial cancer that has a specific molecular profile (pMMR/MSS and no POLE mutation). It aims to understand why these tumors behave the way they do.
This study follows women who carry BRCA1 or BRCA2 gene variants (or a gene variant of unclear meaning) to learn about their risks over time. It may help improve how genetic information is used to guide future care.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.